Literature DB >> 17928206

Long-circulating, pH-sensitive liposomes sterically stabilized by copolymers bearing short blocks of lipid-mimetic units.

Denitsa Momekova1, Stanislav Rangelov, Stanislav Yanev, Elena Nikolova, Spiro Konstantinov, Birgit Romberg, Gert Storm, Nikolay Lambov.   

Abstract

A major hurdle towards in vivo utilization of pH-sensitive liposomes is their prompt sequestration by reticuloendothelial system and hence short circulation time. Prolonged circulation of liposomes is usually achieved by incorporation of pegylated lipids, which have been frequently reported to deteriorate the acid-triggered release. In this study we evaluate the ability of four novel nonionic copolymers, bearing short blocks of lipid-mimetic units to provide steric stabilization of DOPE:CHEMs liposomes. The vesicles were prepared using the lipid film hydration method and extrusion, yielding liposomes of 120-160 nm in size. Their pH-sensitivity was monitored via the release of encapsulated calcein. The incorporation of the block copolymers at concentration up to 10 mol% did not deteriorate the pH-sensitivity of the liposomes. A selected formulation was tested for stability in presence of 25% human plasma and proved to significantly outclass the plain DOPE:CHEMs liposomes. The ability of calcein-loaded liposomes to deliver their cargo inside EJ cells was investigated using fluorescent microscopy and the results show that the surface-modified vesicles are as effective to ensure intracellular delivery as plain liposomes. The pharmacokinetics and organ distribution of a selected formulation, containing a copolymer bearing four lipid anchors was investigated in comparison to plain liposomes and PEG (2000)-DSPE stabilized liposomes. The juxtaposition of the blood clearance curves and the calculated pharmacokinetic parameters show that the block copolymer confers superior longevity in vivo. The block copolymers utilized in this study can be consider as promising sterically stabilizing agents for pH-sensitive liposomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928206     DOI: 10.1016/j.ejps.2007.08.009

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

1.  Calcein release from polymeric vesicles in blood plasma and PVA hydrogel.

Authors:  S Litvinchuk; Z Lu; P Rigler; T D Hirt; W Meier
Journal:  Pharm Res       Date:  2009-04-21       Impact factor: 4.200

Review 2.  Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.

Authors:  Shu Wang; Rui Su; Shufang Nie; Ming Sun; Jia Zhang; Dayong Wu; Naima Moustaid-Moussa
Journal:  J Nutr Biochem       Date:  2013-11-05       Impact factor: 6.048

Review 3.  Bioengineering strategies for designing targeted cancer therapies.

Authors:  Angela A Alexander-Bryant; Wendy S Vanden Berg-Foels; Xuejun Wen
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

4.  Development of nanoparticles incorporating a novel liposomal membrane destabilization peptide for efficient release of cargos into cancer cells.

Authors:  Shoko Itakura; Susumu Hama; Takashi Ohgita; Kentaro Kogure
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

5.  Quantification of sterol-specific response in human macrophages using automated imaged-based analysis.

Authors:  Deborah L Gater; Namareq Widatalla; Kinza Islam; Maryam AlRaeesi; Jeremy C M Teo; Yanthe E Pearson
Journal:  Lipids Health Dis       Date:  2017-12-13       Impact factor: 3.876

6.  Formulation, characterization and tissue distribution of a novel pH-sensitive long-circulating liposome-based theranostic suitable for molecular imaging and drug delivery.

Authors:  Yin Duan; Lihui Wei; Julia Petryk; Terrence D Ruddy
Journal:  Int J Nanomedicine       Date:  2016-11-01

7.  Optimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM).

Authors:  Yuangang Zu; Yu Zhang; Xiuhua Zhao; Qi Zhang; Yang Liu; Ru Jiang
Journal:  Int J Nanomedicine       Date:  2009-12-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.